These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 17494512)
41. Accumulation of neurofilaments in a sporadic case of amyotrophic lateral sclerosis. Kondo A; Iwaki T; Tateishi J; Kirimoto K; Morimoto T; Oomura I Jpn J Psychiatry Neurol; 1986 Dec; 40(4):677-84. PubMed ID: 3110473 [TBL] [Abstract][Full Text] [Related]
42. [A clinicopathological study of two respirator-aided long-survival cases of amyotrophic lateral sclerosis]. Yoshida M; Murakami N; Hashizume Y; Itoh E; Takahashi A Rinsho Shinkeigaku; 1992 Mar; 32(3):259-65. PubMed ID: 1628448 [TBL] [Abstract][Full Text] [Related]
43. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis. Mori F; Tanji K; Miki Y; Wakabayashi K J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197 [TBL] [Abstract][Full Text] [Related]
44. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease. Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475 [TBL] [Abstract][Full Text] [Related]
45. Zinc transporters ZnT3 and ZnT6 are downregulated in the spinal cords of patients with sporadic amyotrophic lateral sclerosis. Kaneko M; Noguchi T; Ikegami S; Sakurai T; Kakita A; Toyoshima Y; Kambe T; Yamada M; Inden M; Hara H; Oyanagi K; Inuzuka T; Takahashi H; Hozumi I J Neurosci Res; 2015 Feb; 93(2):370-9. PubMed ID: 25284286 [TBL] [Abstract][Full Text] [Related]
46. Selective overexpression of gamma1 laminin in astrocytes in amyotrophic lateral sclerosis indicates an involvement in ALS pathology. Wiksten M; Väänänen A; Liesi P J Neurosci Res; 2007 Jul; 85(9):2045-58. PubMed ID: 17554784 [TBL] [Abstract][Full Text] [Related]
47. Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients. Deepa P; Shahani N; Alladi PA; Vijayalakshmi K; Sathyaprabha TN; Nalini A; Ravi V; Raju TR J Neural Transm (Vienna); 2011 Apr; 118(4):531-8. PubMed ID: 21069391 [TBL] [Abstract][Full Text] [Related]
48. Substantial early, but nonprogressive neuronal loss in multiple sclerosis (MS) spinal cord. Schirmer L; Albert M; Buss A; Schulz-Schaeffer WJ; Antel JP; Brück W; Stadelmann C Ann Neurol; 2009 Nov; 66(5):698-704. PubMed ID: 19938172 [TBL] [Abstract][Full Text] [Related]
49. 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis. Cohen-Adad J; Zhao W; Keil B; Ratai EM; Triantafyllou C; Lawson R; Dheel C; Wald LL; Rosen BR; Cudkowicz M; Atassi N Muscle Nerve; 2013 May; 47(5):760-2. PubMed ID: 23553571 [TBL] [Abstract][Full Text] [Related]
50. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice. Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737 [TBL] [Abstract][Full Text] [Related]
52. [The clinico-pathological findings of the patients grouped as respiratory motor paralysis preceded type of ALS]. Hayashi H; Kato S; Oda M No To Shinkei; 1999 Sep; 51(9):771-8. PubMed ID: 10511954 [TBL] [Abstract][Full Text] [Related]
53. PARP expression is increased in astrocytes but decreased in motor neurons in the spinal cord of sporadic ALS patients. Kim SH; Henkel JS; Beers DR; Sengun IS; Simpson EP; Goodman JC; Engelhardt JI; Siklós L; Appel SH J Neuropathol Exp Neurol; 2003 Jan; 62(1):88-103. PubMed ID: 12528821 [TBL] [Abstract][Full Text] [Related]
54. Increased [35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Lanius RA; Krieger C; Wagey R; Shaw CA Neurosci Lett; 1993 Nov; 163(1):89-92. PubMed ID: 8295742 [TBL] [Abstract][Full Text] [Related]
56. AMPA receptor-mediated neuronal death in sporadic ALS. Kwak S; Hideyama T; Yamashita T; Aizawa H Neuropathology; 2010 Apr; 30(2):182-8. PubMed ID: 20102521 [TBL] [Abstract][Full Text] [Related]
57. Expression of secreted phosphoprotein 1 (osteopontin) in human sensorimotor cortex and spinal cord: Changes in patients with amyotrophic lateral sclerosis. Yamamoto T; Murayama S; Takao M; Isa T; Higo N Brain Res; 2017 Jan; 1655():168-175. PubMed ID: 27823929 [TBL] [Abstract][Full Text] [Related]
58. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model. Arima H; Omura T; Hayasaka T; Masaki N; Hanada M; Xu D; Banno T; Kobayashi K; Takeuchi H; Kadomatsu K; Matsuyama Y; Setou M Neuroscience; 2015 Jun; 297():127-36. PubMed ID: 25841322 [TBL] [Abstract][Full Text] [Related]
59. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Sillevis Smitt PA; Blaauwgeers HG; Troost D; de Jong JM Neurosci Lett; 1992 Sep; 144(1-2):107-10. PubMed ID: 1436688 [TBL] [Abstract][Full Text] [Related]
60. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Takahashi H; Oyanagi K; Ikuta F Acta Neuropathol; 1993; 86(2):190-2. PubMed ID: 8213074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]